The Microbiome and Cancer Treatment
Overcoming Resistance and Enhancing Efficacy
- 1 Edición - 8 de septiembre de 2026
- Última edición
- Editores: Sadhna Aggarwal, Garima Malik, Arun Kumar Singh, Meenakshi Dhanawat
- Idioma: Inglés
The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highli… Leer más
Descripción
Descripción
The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance.
Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.
Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.
Puntos claves
Puntos claves
- Fosters a comprehensive understanding of the microbiome's role in cancer treatment, encouraging collaboration among researchers and healthcare professionals to develop holistic and innovative therapeutic strategies
- Provides practical insights into microbiome-based strategies to overcome chemoresistance, such as the use of probiotics and prebiotics in cancer therapy
- Explores how modulating the gut microbiome can enhance the efficacy of immunotherapies, offering actionable knowledge for the development of personalized and more effective cancer treatments
De interès para
De interès para
Researchers, healthcare professionals, and academics in the fields of oncology, microbiology, immunology, and pharmacology
Índice
Índice
1. Understanding the Microbiome: Microbiome and Immune System Interactions
2. The Microbiome: Its Impact on Cancer Development and Therapeutic Responses
3. Microbiome Dynamics in Cancer Treatment: Impact of Chemotherapy on the Microbiome
4. Microbiome as a Modulator of Immunotherapy: Synergistic Effects of the Microbiome in Immunotherapy
5. Microbiome-Based Strategies to Overcome Chemoresistance: Probiotics and Prebiotics in Cancer Therapy
6. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
7. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
8. Cancer pharmacomicrobiomics: targeting microbiota to optimize cancer therapy outcomes
9. Gut microbiome in modulating immune checkpoint inhibitors
10. Microbiome-based diagnostics and biomarkers: The search for mechanistic connections
11. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
12. Current challenges and Future Prospects for Microbiome Research in Cancer Treatment
2. The Microbiome: Its Impact on Cancer Development and Therapeutic Responses
3. Microbiome Dynamics in Cancer Treatment: Impact of Chemotherapy on the Microbiome
4. Microbiome as a Modulator of Immunotherapy: Synergistic Effects of the Microbiome in Immunotherapy
5. Microbiome-Based Strategies to Overcome Chemoresistance: Probiotics and Prebiotics in Cancer Therapy
6. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
7. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
8. Cancer pharmacomicrobiomics: targeting microbiota to optimize cancer therapy outcomes
9. Gut microbiome in modulating immune checkpoint inhibitors
10. Microbiome-based diagnostics and biomarkers: The search for mechanistic connections
11. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
12. Current challenges and Future Prospects for Microbiome Research in Cancer Treatment
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Publicado: 11 de septiembre de 2026
- Idioma: Inglés
Sobre los editores
Sobre los editores
SA
Sadhna Aggarwal
Dr. Aggarwal is currently a senior postdoctoral fellow at the MD Anderson Cancer Center, Texas, USA. She completed Ph.D. from AIIMS, New Delhi under supervision of Prof. S. N. Das. During PhD, wherein she successfully addressed various aspects of local immunopathology in oral squamous cell carcinoma (OSCC). She published dozens of articles and several book chapters. She is an editorial board member of several indexed reputed international journals.
Afiliaciones y experiencia
MD Anderson Cancer Center, TX, USAGM
Garima Malik
Garima Malik has completed her B. Pharmacy from Vaish Institute of Pharmaceutical Education and Research, Rohtak, and an M.Pharmacy from Chandigarh College of Pharmacy, Landran. She has more than 3 years of experience as an Assistant Professor in the Department of Pharmaceutics. Currently, she is working as an Assistant Professor at M.M College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala, India. Ms Garima had about 1.5 years of experience as an officer in the Quality control department at Zenacts Pharma Manimajra, Chandigarh. Her M.Pharmacy project focused on the topic of “Preparation and evaluation of Fusidic acid loaded transferosomes amalgamated with gel for the management of burn wound infection”. She has published more than 10 publications, including 1 Patent, and 5 book chapters. Her area of interest is nanotechnology, hydrogels, biomaterials, and their application in drug delivery.
Afiliaciones y experiencia
Chitkara college of pharmacy, Chitkara University Rajpura, Punjab, IndiaAS
Arun Kumar Singh
Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at Vivekanand Global University, India. His teaching and research activities span pharmaceutical sciences and a range of interdisciplinary fields, including nanoformulation, cancer biology, artificial intelligence, machine learning, blockchain technology, the Internet of Things, big data analytics, and neuroscience. He has contributed to scholarly publishing through authorship and editorial work and has participated in research and academic initiatives that integrate emerging technologies with healthcare and pharmaceutical applications. His interests focus on advancing innovative approaches to drug delivery, biomedical research, and technology-enabled solutions for healthcare challenges.
Afiliaciones y experiencia
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab, IndiaMD
Meenakshi Dhanawat
Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with many years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence.
Afiliaciones y experiencia
Associate Professor, Amity Institute of Pharmacy, Amity University, Haryana, IndiaVer libro en ScienceDirect
Ver libro en ScienceDirect
Lee The Microbiome and Cancer Treatment en ScienceDirect